BORMANN-KENNEDY BARBARA-JEAN ANNE sold 9.5% of their position (15K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $106.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/15/2025ACC: 0001635065-25-000004
Director
Since Oct 2021
-15K
Net shares
Net seller
$106.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$7.09
Trade value
$106.41K
% of position
9.5%
12/12/2025
157.50K→142.50K
Total
Net shares
−15K
Net value
-$106.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | S · Sale | −15K | $7.09 | $106.41K | 9.5% | 157.50K | 142.50K |
| Total | −15K | -$106.41K | ||||||
Derivative Transactions0
No derivative transactions reported